Show simple item record

How is the serum concentration of Lamotrigine in polytherapy patients with epilepsy affected by the L48V genetic polymorphism or by smoking?

dc.contributor.authorGoren, M. Z.
dc.contributor.authorOzkara, C.
dc.contributor.authorOzkaynakci, A.
dc.contributor.authorGulhan, R.
dc.contributor.authorOnat, F.
dc.contributor.authorOglu, Gulcebi Idriz M.
dc.date.accessioned2021-03-06T21:15:34Z
dc.date.available2021-03-06T21:15:34Z
dc.identifier.citationOglu G. I. M. , Ozkaynakci A., Goren M. Z. , Ozkara C., Gulhan R., Onat F., "How is the serum concentration of Lamotrigine in polytherapy patients with epilepsy affected by the L48V genetic polymorphism or by smoking?", 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Almanya, 2 - 06 Ekim 2011, cilt.33, ss.521
dc.identifier.othervv_1032021
dc.identifier.otherav_fde80aaf-6c1f-4d3c-8f0c-632f50337cc8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/166086
dc.language.isoeng
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTOKSİKOLOJİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectMeslek Bilimleri
dc.subjectFarmasötik Toksikoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectKlinik Tıp
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.titleHow is the serum concentration of Lamotrigine in polytherapy patients with epilepsy affected by the L48V genetic polymorphism or by smoking?
dc.typeBildiri
dc.contributor.departmentMarmara Üniversitesi , ,
dc.identifier.volume33
dc.contributor.firstauthorID138394


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record